Autoantibodies Could Help Predict Cancer Risk in Scleroderma Autoantibodies Could Help Predict Cancer Risk in Scleroderma

The autoantibodies anti-POLR3 and monospecific anti-Ro52 were associated with increased cancer risk, while anti-centromere and anti-U1RNP were tied to reduced risk.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology News Source Type: news